Are Investors Undervaluing VEON (VEON) Right Now?

Zacks Equity Research highlights VEON (VEON) as a compelling value investment, assigning it a Zacks Rank #1 (Strong Buy) and a Value grade of A. The company trades at a P/E ratio of 6.62, significantly below its industry average of 18.82, and a P/S ratio of 0.97, compared to the industry's 1.25. These metrics, coupled with a strong earnings outlook, indicate VEON is likely undervalued, presenting it as a strong pick for value-oriented portfolios.

Analysis

VEON (VEON) has been identified by Zacks Equity Research as a compelling value opportunity, meriting a Zacks Rank #1 (Strong Buy) and a Value grade of 'A'. The company's valuation appears significantly discounted relative to its peers, with a current P/E ratio of 6.62, which is nearly a third of the industry average of 18.82. This undervaluation is further supported by its historical forward P/E, which has ranged between 6.13 and 10.57 over the past year, indicating the current multiple is near its 12-month low. Additionally, VEON's price-to-sales (P/S) ratio of 0.97 is below the industry benchmark of 1.25, a metric often favored for its reliability. The combination of these depressed valuation multiples with a strong earnings outlook, as implied by the top Zacks Rank, positions VEON as a noteworthy candidate for value-focused investors.

Key Decisions for Investors

• Given the 'Strong Buy' rating and significant valuation discount on both P/E and P/S metrics, investors with a value-oriented mandate should consider initiating or adding to a position in VEON.
• Investors should monitor key valuation levels, as the stock's current P/E of 6.62 is near its 52-week low of 6.13, and a sustained break above the median of 8.78 would be a bullish technical confirmation.
• While the Zacks Rank is based on positive earnings estimate revisions, further due diligence is warranted to understand the fundamental drivers behind this improved outlook, as these specifics are not detailed in the report.